Diabetes Education and Control Group, Kidney and Hypertension Hospital, Federal University of São Paulo, São Paulo, Brazil.
Diabetes Technol Ther. 2011 Oct;13(10):997-1004. doi: 10.1089/dia.2011.0054. Epub 2011 Jul 13.
We evaluated intensive intervention in poorly controlled patients with type 2 diabetes mellitus involving weekly clinic visits and adjustment of therapy with analysis of three seven-point glucose profiles and intervention from an interdisciplinary staff.
Sixty-three patients were randomized to an intensive treatment group that obtained self-monitoring of blood glucose (SMBG) profiles (six or seven values per day, 3 days/week) and were seen in the clinic at Weeks 1-6 and 12. SMBG results were downloaded, analyzed using Accu-Chek(®) 360° software (Roche Diagnostics, Indianapolis, IN), and used to adjust therapy. Control group subjects obtained glucose profiles and had clinic visits only at Weeks 0, 6, and 12.
There were highly statistically significant improvements in the intensive treatment group compared with the control group between Weeks 0 and 6 with greater reductions in weekly mean glycemia (WMG) (-76.7±8.9 mg/dL vs. -20.5±8.1 mg/dL), glycemic variability (SD) (-16.3±3.1 mg/dL vs. -5.0±3.1 mg/dL), and glycated hemoglobin (-1.82±0.16% vs. -0.66±0.22%) without significant changes in frequency of hypoglycemia or weight. Improvements were sustained in the intensive treatment group through Week 12. A minimal but statistically significant degree of improvement was seen in the control group at Week 12.
This short-term pilot study of an intensive monitoring, educational, and pharmacological interventions program resulted in dramatic improvement of glycemic control within 6 weeks, and these effects are sustained through Week 12. SMBG glucose profiles, calculation of WMG and SD, and graphical displays of glucose data can improve the effectiveness of adjustment of therapy at weekly clinic visits when combined with intensive support from a multidisciplinary team.
我们评估了涉及每周门诊就诊和治疗调整的 2 型糖尿病患者强化干预,治疗调整通过分析 3 个七点血糖谱和来自跨学科团队的干预进行。
63 名患者被随机分为强化治疗组,该组患者接受自我监测血糖(SMBG)谱(每天 6 或 7 个值,每周 3 天),并在第 1-6 周和第 12 周在门诊就诊。SMBG 结果被下载,使用 Accu-Chek(®) 360°软件(罗氏诊断公司,印第安纳波利斯,IN)进行分析,并用于调整治疗。对照组患者仅在第 0、6 和 12 周获得血糖谱并就诊。
强化治疗组与对照组相比,在第 0 至 6 周之间有统计学意义上的显著改善,每周平均血糖(WMG)(-76.7±8.9 mg/dL 与-20.5±8.1 mg/dL)、血糖变异性(SD)(-16.3±3.1 mg/dL 与-5.0±3.1 mg/dL)和糖化血红蛋白(-1.82±0.16%与-0.66±0.22%)的降低幅度更大,而低血糖或体重无显著变化。强化治疗组的改善在第 12 周仍持续。对照组在第 12 周也有一定程度的改善,但无统计学意义。
这项强化监测、教育和药物干预方案的短期试点研究在 6 周内显著改善了血糖控制,这些效果在第 12 周仍持续。SMBG 血糖谱、WMG 和 SD 的计算以及血糖数据的图形显示可以提高每周门诊就诊时治疗调整的效果,当与多学科团队的强化支持相结合时。